QQ客服 官方微博 反馈留言

	Fucoidan inhibits CCL22 production through NF-kappa B pathway in M2 macrophages: a potential therapeutic strategy for cancer
	Sun, Jia; Sun, Jintang; Song, Bingfeng; Zhang, Lin; Shao, Qianqian; Liu, Yanguo; Yuan, Daoying; Zhang, Yun; Qu, Xun
刊名	SCIENTIFIC REPORTS
	2016
卷号	6
DOI	10.1038/srep35855
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4688813
专题	山东大学
作者单位	Shandong Univ, Qilu Hosp, Inst Basic Med Sci, Jinan 250012,
推荐引用方式 GB/T 7714	Sun, Jia,Sun, Jintang,Song, Bingfeng,et al. Fucoidan inhibits CCL22 production through NF-kappa B pathway in M2 macrophages: a potential therapeutic strategy for cancer[J]. SCIENTIFIC REPORTS,2016,6.
APA	Sun, Jia.,Sun, Jintang.,Song, Bingfeng.,Zhang, Lin.,Shao, Qianqian.,...&Qu, Xun.(2016).Fucoidan inhibits CCL22 production through NF-kappa B pathway in M2 macrophages: a potential therapeutic strategy for cancer.SCIENTIFIC REPORTS,6.
MLA	Sun, Jia,et al."Fucoidan inhibits CCL22 production through NF-kappa B pathway in M2 macrophages: a potential therapeutic strategy for cancer".SCIENTIFIC REPORTS 6(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。